{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:56:31Z","timestamp":1792090591836,"version":"4.4.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009128","name":"Research for Patient Benefit Programme","doi-asserted-by":"publisher","award":["201973"],"award-info":[{"award-number":["201973"]}],"id":[{"id":"10.13039\/501100009128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>To explore barriers and facilitators to COVID-19, influenza, and pneumococcal vaccine uptake in immunosuppressed adults with immune-mediated inflammatory diseases (IMIDs).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Recruiting through national patient charities and a local hospital, participants were invited to take part in an in-depth, one-to-one, semi-structured interview with a trained qualitative researcher between November 2021 and January 2022. Data were analysed thematically in NVivo, cross-validated by a second coder and mapped to the SAGE vaccine hesitancy matrix.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Twenty participants (75% female, 20% non-white) were recruited. Barriers and facilitators spanned contextual, individual\/group and vaccine\/vaccination-specific factors. Key facilitators to all vaccines were higher perceived infection risk and belief that vaccination is beneficial. Key barriers to all vaccines were belief that vaccination could trigger IMID flare, and active IMID. Key facilitators specific to COVID-19 vaccines included media focus, high incidence, mass-vaccination programme with visible impact, social responsibility, and healthcare professionals\u2019 (HCP) confirmation of the new vaccines\u2019 suitability for their IMID. Novel vaccine technology was a concern, not a barrier. Key facilitators of influenza\/pneumococcal vaccines were awareness of eligibility, direct invitation, and, clear recommendation from trusted HCP. Key barriers of influenza\/pneumococcal vaccines were unaware of eligibility, no direct invitation or recommendation from HCP, low perceived infection risk, and no perceived benefit from vaccination.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Numerous barriers and facilitators to vaccination, varying by vaccine-type, exist for immunosuppressed-IMID patients. Addressing vaccine benefits and safety for IMID-patients in clinical practice, direct invitation, and public-health messaging highlighting immunosuppression as key vaccination-eligibility criteria may optimise uptake, although further research should assess this.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0267769","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T20:10:59Z","timestamp":1662754259000},"page":"e0267769","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic"],"prefix":"10.1371","volume":"17","author":[{"given":"Amy","family":"Fuller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Hancox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Vedhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Card","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mallen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S. Nguyen","family":"Van-Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Abhishek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"issue":"5","key":"pone.0267769.ref001","first-page":"736","article-title":"Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study","volume":"56","author":"A Abhishek","year":"2017","journal-title":"Rheumatology (Oxford, England)"},{"issue":"4","key":"pone.0267769.ref002","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis","volume":"53","author":"LE Dean","year":"2014","journal-title":"Rheumatology (Oxford, England)"},{"issue":"1","key":"pone.0267769.ref003","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/annrheumdis-2014-206334","article-title":"The incidence and prevalence of systemic lupus erythematosus in the UK, 1999\u20132012","volume":"75","author":"F Rees","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"pone.0267769.ref004","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/apt.15701","article-title":"Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000\u20132018","volume":"51","author":"D King","year":"2020","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"pone.0267769.ref005","article-title":"Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study","author":"AK Clift","year":"2020","journal-title":"BMJ"},{"issue":"7821","key":"pone.0267769.ref006","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"EJ Williamson","year":"2020","journal-title":"Nature"},{"key":"pone.0267769.ref007","article-title":"Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study","author":"WA Blumentals","year":"2012","journal-title":"BMC Musculoskelet Disord."},{"issue":"2","key":"pone.0267769.ref008","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ibd\/izy243","article-title":"Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease","volume":"25","author":"A Tinsley","year":"2019","journal-title":"Inflammatory Bowel Diseases"},{"key":"pone.0267769.ref009","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tmaid.2018.05.016","article-title":"Incidence of invasive pneumococcal disease in immunocompromised patients: A systematic review and meta-analysis","volume":"24","author":"M van Aalst","year":"2018","journal-title":"Travel Medicine and Infectious Disease"},{"issue":"2","key":"pone.0267769.ref010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/cid\/civ803","article-title":"Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs","volume":"62","author":"A Shigayeva","year":"2016","journal-title":"Clinical Infectious Diseases"},{"key":"pone.0267769.ref011","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2017.03.011","article-title":"Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis","volume":"80","author":"A Lopez","year":"2017","journal-title":"Journal of Autoimmunity"},{"issue":"12","key":"pone.0267769.ref012","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/annrheumdis-2020-217255","article-title":"Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis","volume":"79","author":"RE Costello","year":"2020","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"10","key":"pone.0267769.ref013","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/rheumatology\/key156","article-title":"Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study","volume":"57","author":"G Nakafero","year":"2018","journal-title":"Rheumatology (Oxford, England)"},{"issue":"6","key":"pone.0267769.ref014","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/art.42067","article-title":"COVID-19 Vaccine Uptake and Vaccine Hesitancy in Rheumatology Patients Receiving Immunomodulatory Therapies Treated In Community Practice Settings","volume":"74","author":"SS Ledbetter","year":"2022","journal-title":"Arthritis & Rheumatology"},{"issue":"4","key":"pone.0267769.ref015","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1016\/S2665-9913(21)00039-4","article-title":"Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases","volume":"3","author":"R Felten","year":"2021","journal-title":"The Lancet Rheumatology"},{"issue":"3","key":"pone.0267769.ref016","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1016\/S2665-9913(21)00368-4","article-title":"Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries","volume":"4","author":"L El Kibbi","year":"2022","journal-title":"The Lancet Rheumatology"},{"issue":"8","key":"pone.0267769.ref017","first-page":"e30","article-title":"American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2","volume":"73","author":"JR Curtis","year":"2021","journal-title":"Arthritis & Rheumatology (Hoboken, NJ)"},{"key":"pone.0267769.ref018","author":"Department of Health & Social Care","year":"2021","journal-title":"Immunisation against infectious disease. Chapter 19: Influenza"},{"issue":"2","key":"pone.0267769.ref019","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"V Braun","year":"2006","journal-title":"Qualitative Research in Psychology"},{"issue":"34","key":"pone.0267769.ref020","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: Definition, scope and determinants","volume":"33","author":"NE MacDonald","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"pone.0267769.ref021","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1093\/rheumatology\/keab471","article-title":"Barriers and facilitators to influenza and pneumococcal vaccine hesitancy in rheumatoid arthritis: a qualitative study","volume":"60","author":"I Colmegna","year":"2021","journal-title":"Rheumatology (Oxford, England)"},{"key":"pone.0267769.ref022","article-title":"Women\u2019s views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK","author":"H Skirrow","year":"2022","journal-title":"BMC Pregnancy and Childbirth"},{"key":"pone.0267769.ref023","article-title":"Exploration of attitudes regarding uptake of COVID-19 vaccines among vaccine hesitant adults in the UK: a qualitative analysis","author":"S Denford","year":"2022","journal-title":"BMC Infectious Diseases"},{"issue":"6","key":"pone.0267769.ref024","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.dld.2017.12.027","article-title":"Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study","volume":"50","author":"P Loubet","year":"2018","journal-title":"Digestive and Liver Disease"},{"issue":"6","key":"pone.0267769.ref025","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/03009742.2016.1242774","article-title":"Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA)","volume":"46","author":"M Nguyen","year":"2017","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"5","key":"pone.0267769.ref026","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2665-9913(22)00009-1","article-title":"COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases","volume":"4","author":"L Boekel","year":"2022","journal-title":"The Lancet Rheumatology"},{"issue":"1","key":"pone.0267769.ref027","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/acr2.11351","article-title":"Acceptability of vaccines against preventable infections including coronavirus disease 2019 among patients with rheumatic disease","volume":"4","author":"SK Tedeschi","year":"2022","journal-title":"ACR Open Rheumatology"},{"key":"pone.0267769.ref028","article-title":"Exploring the Continuum of Vaccine Hesitancy Between African American and White Adults: Results of a Qualitative Study","author":"S Quinn","year":"2016","journal-title":"PLOS Currents"},{"issue":"6","key":"pone.0267769.ref029","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.semarthrit.2015.01.002","article-title":"Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus","volume":"44","author":"EF Lawson","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"pone.0267769.ref030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/ecco-jcc\/jjv064","article-title":"Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake","volume":"9","author":"G Malhi","year":"2015","journal-title":"Journal of Crohn\u2019s & Colitis"},{"issue":"4","key":"pone.0267769.ref031","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2665-9913(22)00001-7","article-title":"COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey","volume":"4","author":"M Putman","year":"2022","journal-title":"The Lancet Rheumatology"},{"key":"pone.0267769.ref032","article-title":"A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK","author":"S Subesinghe","journal-title":"BMC Musculoskeletal Disorders"},{"key":"pone.0267769.ref033","article-title":"Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom","author":"J Murphy","year":"2021","journal-title":"Nature Communications"},{"issue":"SI","key":"pone.0267769.ref034","doi-asserted-by":"crossref","first-page":"SI68","DOI":"10.1093\/rheumatology\/keab432","article-title":"Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases","volume":"60","author":"R Felten","year":"2021","journal-title":"Rheumatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0267769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T20:11:32Z","timestamp":1662754292000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0267769"}},"subtitle":[],"editor":[{"given":"Latika","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0267769","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]}}}